Literature DB >> 19047432

Meningitis.

Keith Mann1, Mary Anne Jackson.   

Abstract

* Young infants who have meningitis may present with nonspecific clinical manifestations. * S. pneumoniae and N. meningitidis remain the most common causes of bacterial meningitis in the infant and child, and GBS continues to be the most common neonatal pathogen. * Empiric therapy for suspected bacterial meningitis in a non-neonate includes a combination of parenteral vancomycin and either cefotaxime or ceftriaxone. * Children whose GCS scores are less than 8, show signs of shock or respiratory compromise, and have focal neurologic findings or clinical signs of elevated intracranial pressure should be admitted to a pediatric intensive care unit. * Sensorineural hearing loss occurs in 30% of children who have pneumococcal and 10% of those who have meningococcal meningitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047432     DOI: 10.1542/pir.29-12-417

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN: 0191-9601


  12 in total

1.  Clinical features of bacterial meningitis among hospitalised children in Kenya.

Authors:  Christina W Obiero; Neema Mturi; Salim Mwarumba; Moses Ngari; Charles R Newton; Michaël Boele van Hensbroek; James A Berkley
Journal:  BMC Med       Date:  2021-06-04       Impact factor: 8.775

2.  Quantitative proteomic analysis of cerebrospinal fluid reveals CD163, A2M and full-length APP as potential diagnostic biomarkers of paediatric bacterial meningitis.

Authors:  Ting Luo; Sai Yang; Yan Chen; Shulei Liu; Liming Yang; Nanfei Hu; Ye Ma; Jun Qiu; Kewei Wang; Liping Li; Lihong Tan
Journal:  Proteome Sci       Date:  2022-05-06       Impact factor: 2.882

3.  Analysis of clinical information and reverse transcriptase-polymerase chain reaction for early diagnosis of enteroviral meningitis.

Authors:  Dahee Jin; Tae Hoon Heo; Jung Hye Byeon; Gun-Ha Kim; Mi Kyung Kim; So-Hee Eun; Baik-Lin Eun
Journal:  Korean J Pediatr       Date:  2015-11-22

4.  Acute Hemiplegia in Children: A Prospective Study of Etiology, Clinical Presentation, and Outcome from Western India.

Authors:  Vasant Chinnabhandar; Amitabh Singh; Anirban Mandal; B J Parmar
Journal:  J Neurosci Rural Pract       Date:  2018 Oct-Dec

5.  Clinical presentations, Laboratory analysis and Linear Growth in 50 Neonates and Young Infants with Acute Meningitis: One Year Experience of a Single Center in Qatar.

Authors:  Nadra Abdelmaguid; Wail Said Seleem; Ashraf T Soliman; Rabie S Mohamed; Fawzia M Elgharbawy; Haytham Yassin; Vincenzo De Sanctis
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-05-01       Impact factor: 2.576

6.  IBUPROFEN-INDUCED ASEPTIC MENINGITIS: A CASE REPORT.

Authors:  Sofia Alexandra Pereira Pires; Ana Pereira Lemos; Ester Preciosa Maio Nunes Pereira; Paulo Alexandre da Silva Vilar Maia; João Patrício de Sousa E Alvim Bismarck do Agro
Journal:  Rev Paul Pediatr       Date:  2019-06-03

7.  High-throughput sequencing of 16S rDNA amplicons characterizes bacterial composition in cerebrospinal fluid samples from patients with purulent meningitis.

Authors:  Aicui Liu; Chao Wang; Zhijuan Liang; Zhi-Wei Zhou; Lin Wang; Qiaoli Ma; Guowei Wang; Shu-Feng Zhou; Zhenhai Wang
Journal:  Drug Des Devel Ther       Date:  2015-08-07       Impact factor: 4.162

Review 8.  Neonatal Meningitis: Overcoming Challenges in Diagnosis, Prognosis, and Treatment with Omics.

Authors:  Scott M Gordon; Lakshmi Srinivasan; Mary Catherine Harris
Journal:  Front Pediatr       Date:  2017-06-16       Impact factor: 3.418

9.  Rapid pathogen identification using a novel microarray-based assay with purulent meningitis in cerebrospinal fluid.

Authors:  Yuting Hou; Xu Zhang; Xiaolin Hou; Ruofen Wu; Yanbai Wang; Xuexian He; Libin Wang; Zhenhai Wang
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

10.  Reagent Strips as an Aid to Diagnosis of Neonatal Meningitis in a Resource-limited Setting.

Authors:  Kathy Burgoine; Juliet Ikiror; Ketty Naizuli; Linda Achom; Sylivia Akol; Peter Olupot-Olupot
Journal:  J Trop Pediatr       Date:  2019-02-01       Impact factor: 1.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.